Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
33.35
+0.14 (0.42%)
Mar 27, 2025, 4:00 PM EST - Market closed
HRMY Employees
Harmony Biosciences Holdings had 268 employees as of December 31, 2024. The number of employees increased by 22 or 8.94% compared to the previous year.
Employees
268
Change (1Y)
22
Growth (1Y)
8.94%
Revenue / Employee
$2,666,918
Profits / Employee
$542,884
Market Cap
1.91B
Employees Chart
HRMY News
- 13 hours ago - Harmony Biosciences Holdings, Inc. (HRMY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Harmony Biosciences Holdings, Inc. (HRMY) and Encourages Stockholders to Learn More About the Investigation - Accesswire
- 1 day ago - Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference - Business Wire
- 2 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Harmony Biosciences Holdings, Inc. (HRMY) Investors to Inquire about Securities Investigation - Accesswire
- 3 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Investors to Reach Out - Accesswire
- 3 days ago - Harmony Biosciences: A Compelling Risk-Reward Opportunity - Seeking Alpha
- 3 days ago - Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands - Business Wire
- 6 days ago - HRMY Investors Have Opportunity to Join Harmony Biosciences Holdings, Inc. Fraud Investigation with the Schall Law Firm - Business Wire